Salivary gland cancer, a rare but significant malignancy, poses considerable challenges in diagnosis and treatment due to its heterogeneous nature. Recent advancements in molecular biology have unveiled critical insights into the molecular pathways driving salivary gland cancer. This review aims to elucidate the key molecular mechanisms involved in salivary gland cancer pathogenesis and highlight potential therapeutic targets that could pave the way for novel treatment strategies.
HTML PDFShare this article
